CASP3 and papillary serous cystadenocarcinoma: In addition, there were statistically significantly lower levels of caspase-3, both in the serum of women with ovarian serous cystadenoma and papillary serous cystadenocarcinoma, compared to the serum levels of women in the control group (p ˂ 0.001), as illustrated in Figure 1.